Treatment of acute cannabinoid overdose
AssigneeAnebulo Pharmaceuticals, Inc.
InventorsJoseph Fenton LAWLER, Daniel Pawel SCHNEEBERGER, Kenneth C. CUNDY
Life of this patent
Estimating the term…
Abstract
Provided herein are methods of treating cannabinoid intoxication. Further provided herein are metrics for evaluation Cannabis intoxication and the amelioration thereof.
Claims47
A method of treating a known or suspected acute cannabinoid intoxication in a subject in need thereof, the method comprising:
- administering to the subject a therapeutically-effective amount of a compound having the structure
- wherein treating improves one or more metrics associated with acute cannabinoid intoxication.
A method of treating a known or suspected acute cannabinoid intoxication in a subject in need thereof, the method comprising:
- administering to the subject a therapeutically-effective amount of a compound having the structure
- wherein the compound has a plasma Cmax of about 100-500 ng/mL.
A method of treating a known or suspected acute cannabinoid intoxication in a subject in need thereof, the method comprising:
- administering to the subject a therapeutically-effective amount of a compound having the structure
- wherein the compound has a plasma AUClast of about 500-2800 h*ng/mL.
A method of treating a known or suspected acute cannabinoid intoxication in a subject in need thereof, the method comprising:
- administering to the subject a therapeutically-effective amount of a compound having the structure
- wherein the compound has a plasma AUC5h of about 100-1200 h*ng/mL.
A method of treating a known or suspected acute cannabinoid intoxication in a subject in need thereof, the method comprising:
- administering to the subject a therapeutically-effective amount of a compound having the structure
- wherein the compound has a dose normalized plasma Cmax of about 3-20 ng/mL/mg.
A method of treating a known or suspected acute cannabinoid intoxication in a subject in need thereof, the method comprising:
- administering to the subject a therapeutically-effective amount of a compound having the structure
- wherein the compound has a dose normalized plasma AUClast of about 50-400 h*ng/mL/mg.
A method of treating a known or suspected acute cannabinoid intoxication in a subject in need thereof, the method comprising:
- administering to the subject a therapeutically-effective amount of a compound having the structure
- wherein the compound has a dosage normalized plasma AUC5h of about 10-40 h*ng/mL/mg.
A method of treating a known or suspected acute cannabinoid intoxication in a subject in need thereof, the method comprising:
- administering to the subject a therapeutically-effective amount of a compound having the structure
- wherein the compound has a Tmax of or less than about 60 minutes.
A method of treating a known or suspected acute cannabinoid intoxication in a subject in need thereof, the method comprising:
- administering to the subject a therapeutically-effective amount of a compound having the structure
- wherein treating accelerates recovery, shortens time in medical care or reduces the effects the intoxication as determined by an acceptable metric evaluation.
A composition comprising a compound having the structure:
Dependencies are inferred from the claim text.